Category: Oncology
How can Artificial intelligence help in medicine?
Artificial intelligence (AI) has the potential to transform medicine in many ways. The machine learning has some examples that may be helpful: Overall, AI has…
H.Pylori infection and Genetics of Gastric Cancer
Helicobacter pylori infection can increase the chances or risk of getting stomach cancer. A research study published in NEJM in March 2023 looked at how…
New FDA approval for Tucatinib (brand name Tukysa) in combination with trastuzumab for RAS wild-type HER2-positive unresectable or metastatic colorectal cancer: MOUNTAINEER study
The MOUNTAINEER trial was a multicenter, open-label study that focused on patients with unresectable or metastatic colorectal cancer who had HER2-positive and RAS wild-type tumors,…
A new treatment Retifanlimab-dlwr (Zynyz) received FDA accelerated approval for Merkel cell carcinoma (a skin cancer type)
Merkel cell carcinoma (MCC) is a type of skin cancer that can be challenging to treat, particularly in its advanced stages. However, a new drug…
Trifluridine/tipiracil (Lonsurf) plus bevacizumab (Avastin) showing response in overall survival for refractory metastatic colorectal cancer: The phase 3, randomized SUNLIGHT study
Metastatic colorectal cancer (mCRC) is a significant cause of cancer-related mortality worldwide. Despite the availability of several treatment options, refractory mCRC remains a challenging clinical…
Treatment of HepatoCellular Cancer (HCC) in advanced and metastatic disease
Hepatocellular carcinoma (HCC) is a type of liver cancer that often develops in individuals with chronic liver disease. Treatment options for HCC depend on the…
Keytruda (Pembrolizumab) role as adjuvant immunotherapy in Kidney Cancer after Nephrectomy
Immunotherapy role (as adjuvant) in Kidney cancer (Renal Cell Cancer) after nephrectomy is evolving. Kidney cancer, also known as renal cell carcinoma, is one of…
Cabozantinib as active treatment in second line advanced/metastatic clear cell Renal cell cancer
The results of the Cabopoint study presented at GU ASCO 2023 indicated that cabozantinib could be a promising second-line treatment option for patients with renal…
NeoAdjuvant Immunotherapy and Chemotherapy in Lung Cancer showed promising results
The Neoadjuvant chemotherapy and immunotherapy are showing promising results in management of Non-small cell lung cancer. Neoadjuvant chemotherapy involves administering chemotherapy drugs before surgery to…
Prostate Cancer: Addition of short-term hormonal therapy to salvage Prostate bed radiation and pelvic lymph node radiation improves outcomes (SPPORT Trial)
The findings published in Lancet in SPPORT trial, an international, multicentre, randomised phase 3 trial. The patients after prostatectomy for prostate cancer who had a…